Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2021
Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible AntigenCalvin D Lewis, Abhay K Singh, Fong-Fu Hsu, et al.International Journal of Cell Biology|June 8, 2012
GSK-3β: A Bifunctional Role in Cell Death PathwaysKeith M Jacobs, Sandeep R Bhave, Daniel J Ferraro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non-Small Cell Lung Cancer Cell Lines and Tumor ModelsDavid Y A Dadey, Vaishali Kapoor, Kelly Hoye, et al.Oncotarget|December 31, 2015
The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastomaDavid Y A Dadey, Vaishali Kapoor, Arpine Khudanyan, et al.International Journal of Molecular Sciences|April 14, 2026
Characterization of Oncogenic and Immunogenic Profiling in Patients with Breast Cancer Tumors After Radiation TherapySuryakant Niture, Carlos E Vargas, Saranya Chumsri, et al.Cancer Research|July 2, 2015
Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 MiceVaishali Kapoor, Arpine Khudanyan, Pilar de la Puente, et al.Journal of Neuro-Oncology|November 17, 2017
Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapyAlexander J Lin, Jian L Campian, Caressa Hui, et al.Plos One|July 30, 2013
Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal modelsDinesh Thotala, Jeffrey M Craft, Daniel J Ferraro, et al.Cancer Immunology Research|March 5, 2020
Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal CancerBaosheng Chen, David M Alvarado, Micah Iticovici, et al.Oncotarget|June 9, 2016
Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancersHeping Yan, Vaishali Kapoor, Kim Nguyen, et al.Pageof 5